Search

everythinglearnresearchcommunity

for

Search:↓

Artefactual skin disorder involves self-inflicted skin lesions linked to mental health issues, needing combined medical and psychological treatment.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Porokeratosis should be considered for scalp lesions, with new treatments like topical cholesterol/lovastatin offering promise.

Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Regular checks and knowing what causes hair loss can help find it early.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Blacks and Hispanics have higher chances of alopecia areata than Whites.

People with chronic hair loss often have lower Vitamin B12 levels.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Moles on the scalp are more common in people with more body moles and atypical moles, but not linked to balding.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.